What is Anna Clark's NPI number?

Anna Clark's National Provider Identifier (NPI) is 1457705733, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Anna Clark's specialty?

Anna Clark is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Anna Clark located?

Anna Clark's practice location on file with NPPES is 500 J Clyde Morris Blvd Fl 2, Newport News, VA 23601-1929.

What is Anna Clark's phone number?

The practice phone number listed in the NPPES registry for Anna Clark is (314) 306-3818.

Does Anna Clark accept Medicare?

Anna Clark is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Anna Clark's NPI active?

Yes — Anna Clark's NPI (1457705733) is active in the NPPES registry as of the last update on 2026-02-24.

IndividualActiveAccepts Medicare

Anna Clark, MD

NPI 1457705733 · Dermatology Physician · Newport News, VA

Anna Clark, MD is a Dermatology Physician provider in Newport News, VA (NPI 1457705733).

Provider details

NPI number: 1457705733
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: 2020029228 (MO)

Practice location

500 J Clyde Morris Blvd Fl 2

Newport News, VA 23601-1929

Phone: (314) 306-3818

Street-level locationGet directions

More VA providers

Mailing address

222 S Woods Mill Rd Ste 480

Chesterfield, MO 63017-3625

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2020029228 (MO)
Allopathic & Osteopathic Physicians
Student in an Organized Health Care Education/Training Program390200000X
Student, Health Care

Additional practice locations (1)

222 S Woods Mill Rd Ste 480
Chesterfield, MO 63017-3625
Phone: (314) 306-3818

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(71/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
10 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
3,201 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,046	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	659	$92
Destruction of Precancer Skin Growth, 1 Growth17000	413	$51
Biopsy of Related Skin Growth, First Growth11102	302	$89
Destruction of Skin Growth, 1-14 Growths17110	230	$112
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	124	95
Clobetasol Propionate	55	39
Doxycycline Hyclate	55	30
Ketoconazole	51	37
Fluocinonide	49	35
Valacyclovir Hclbrand: Valacyclovir	41	11
Tretinoin	41	25
Mupirocin	41	34

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,523 across 217 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2016-04-22
Last updated: 2026-02-24
Certified: 2026-02-24

Frequently asked questions

What is Anna Clark's NPI number?: Anna Clark's National Provider Identifier (NPI) is 1457705733, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Anna Clark's specialty?: Anna Clark is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Anna Clark located?: Anna Clark's practice location on file with NPPES is 500 J Clyde Morris Blvd Fl 2, Newport News, VA 23601-1929.
What is Anna Clark's phone number?: The practice phone number listed in the NPPES registry for Anna Clark is (314) 306-3818.
Does Anna Clark accept Medicare?: Anna Clark is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Anna Clark's NPI active?: Yes — Anna Clark's NPI (1457705733) is active in the NPPES registry as of the last update on 2026-02-24.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,046	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	659	$92
Destruction of Precancer Skin Growth, 1 Growth17000	413	$51
Biopsy of Related Skin Growth, First Growth11102	302	$89
Destruction of Skin Growth, 1-14 Growths17110	230	$112
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Triamcinolone Acetonide

124

Clobetasol Propionate

Doxycycline Hyclate

Ketoconazole

Fluocinonide

Valacyclovir Hclbrand: Valacyclovir

Tretinoin

Mupirocin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,523 across 217 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments